- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Palivizumab is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- J06BB16 Palivizumab · Specific immunoglobulinJ06BD01 Palivizumab · Immunoglobulin therapy, subgroup J06BD
- US FDA first approval
- 19 June 1998
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
- Identifiers
- UNII DQ448MW7KSRxCUI 194279CAS 188039-54-5DrugBank DB00110Q412765
All presentations
No presentations of Palivizumab are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Conditions
Conditions linked to Palivizumab in public data. This is not a list of approved uses, see the clinical information.
Questions and answers
Is Palivizumab available for export from India?
No presentation of Palivizumab is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Palivizumab approved by the US FDA?
Yes. The US FDA first approved Palivizumab on 19 June 1998, according to Drugs@FDA.
Is Palivizumab authorised in the European Union?
Yes. Palivizumab has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Palivizumab need cold chain shipping?
No listed presentation of Palivizumab is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Palivizumab in?
Palivizumab is classified under ATC code J06BB16 (Palivizumab).
References
- Synagis: European public assessment report (EPAR). European Medicines Agency. Retrieved 12 December 2025
Request Palivizumab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.